comparemela.com

Latest Breaking News On - Res clin - Page 1 : comparemela.com

FARXIGA approved in the US for the treatment of pediatric type-2 diabetes

US patients aged 10 years and older can now benefit from FARXIGA for type-2 diabetes Approval based on results from T2NOW, one of the largest pediatric type-2 diabetes Phase III trials to date .

Cambridge
Cambridgeshire
United-kingdom
Germany
United-states
China
National-institute-of-diabetes
International-diabetes-federation
Astrazeneca
Drug-administration
Us-centers-for-disease

FARXIGA approved in the US for the treatment of pediatric type-2 diabetes

FARXIGA approved in the US for the treatment of pediatric type-2 diabetes
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

Cambridge
Cambridgeshire
United-kingdom
Germany
United-states
China
Us-centers-for-disease
National-diabetes-statistics
Astrazeneca
Product-service
International-diabetes-federation

Head-to-head Superiority to High-dose Dulaglutide: Innovent's First Phase 3 Clinical Trial of Mazdutide in Chinese Patients with Type 2 Diabetes Met Study Endpoints

Head-to-head Superiority to High-dose Dulaglutide: Innovent's First Phase 3 Clinical Trial of Mazdutide in Chinese Patients with Type 2 Diabetes Met Study Endpoints
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Japan
Suzhou
Jiangsu
China
Beijing
Chinese
Innovent-biologics
Yang-wenying
Lixin-guo
Eli-lilly
Adimab-incyte
Department-of-endocrinology
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.